IgLON5 deficiency produces behavioral alterations in a knockout mouse model

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Anti-IgLON5 disease is a rare neurological disorder linked to autoantibodies against IgLON5.
• IgLON5 is a brain-expressed cell adhesion molecule with an incompletely understood function.
• Understanding IgLON5's role is crucial for neurodegeneration research.

Purpose of the Study:

• To investigate the functional consequences of IgLON5 loss-of-function.
• To evaluate brain morphology, social behavior, and symptom development in IgLON5 knockout (IgLON5-KO) mice.
• To model aspects of anti-IgLON5 disease in a preclinical setting.

Main Methods:

• IgLON5 knockout (IgLON5-KO) mice were generated using CRISPR-Cas9 gene editing.
• Immunohistochemistry and Western blotting confirmed IgLON5 absence.
• Comprehensive behavioral testing assessed locomotion, memory, anxiety, social interaction, and depressive-like behaviors in IgLON5-KO and wild-type mice.

Main Results:

• IgLON5-KO mice did not exhibit neurological symptoms similar to human anti-IgLON5 disease patients.
• Subtle alterations in motor coordination and balance were observed in 2-month-old IgLON5-KO mice.
• Sex-specific behavioral differences included hyperactivity in females and depressive-like behavior with excessive nest-building in males.

Conclusions:

• Loss of IgLON5 function in mice leads to subtle behavioral and motor coordination deficits.
• IgLON5-KO mice do not recapitulate the full clinical phenotype of anti-IgLON5 disease.
• Further research is needed to fully elucidate IgLON5's role in brain function and disease.